Novo Nordisk
NVO
#26
Rank
HK$2.925 T
Marketcap
HK$663.55
Share price
-2.65%
Change (1 day)
-22.10%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): HK$139.24 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are HK$39.69 Billion. In 2023 the company made an earning of HK$120.18 Billion, an increase over its 2022 earnings that were of HK$76.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$139.24 B15.86%
2023 HK$120.18 B57.64%
2022 HK$76.23 B5.35%
2021 HK$72.36 B12.47%
2020 HK$64.34 B13.07%
2019 HK$56.90 B-3.35%
2018 HK$58.87 B1.79%
2017 HK$57.84 B4.52%
2016 HK$55.33 B9.42%
2015 HK$50.57 B8.24%
2014 HK$46.72 B3.45%
2013 HK$45.16 B19.02%
2012 HK$37.95 B15.21%
2011 HK$32.94 B17.71%
2010 HK$27.98 B24.78%
2009 HK$22.42 B10.62%
2008 HK$20.27 B55.97%
2007 HK$12.99 B7.07%
2006 HK$12.14 B18.18%
2005 HK$10.27 B11.33%
2004 HK$9.22 B
2002 HK$5.63 B-14.39%
2001 HK$6.58 B-52.82%
2000 HK$13.95 B250%
1999 HK$3.98 B31.21%
1998 HK$3.03 B34.31%
1997 HK$2.26 B11.46%
1996 HK$2.02 B9.03%
1995 HK$1.86 B-3.15%
1994 HK$1.92 B-0.67%
1993 HK$1.93 B45.38%
1992 HK$1.33 B-13.81%
1991 HK$1.54 B37.12%
1990 HK$1.12 B-0.79%
1989 HK$1.13 B26.2%
1988 HK$0.89 B24.97%
1987 HK$0.71 B-0.9%
1986 HK$0.72 B-7.78%
1985 HK$0.78 B24.87%
1984 HK$0.63 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$54.07 B-61.09%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$79.06 B-43.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$53.59 Billion-138.56%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$57.70 B-58.48%๐Ÿ‡ซ๐Ÿ‡ท France